Arkolith/Insider Trading/SYRE/Form 4

Turtle Cameron

Chief Executive Officer, DirectorSpyre Therapeutics, Inc. (SYRE) · full profile →Form 4 · filed Jun 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 1, 2026Sell(S)4K$69.40$247K609K
Jun 1, 2026Sell(S)8K$70.50$575K601K
Jun 1, 2026Sell(S)3K$71.38$235K598K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001636282-26-000077) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML